Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/ovarian-cancer-statistics-2018-kl5CM9rj09
References (92)
-
F. Nezhat, T. Pejovic, F. Reis, Sun-Wei Guo (2014)
The Link Between Endometriosis and Ovarian Cancer: Clinical ImplicationsInternational Journal of Gynecologic Cancer, 24
-
Kenneth Lee, R. Young (2003)
The Distinction Between Primary and Metastatic Mucinous Carcinomas of the Ovary: Gross and Histologic Findings in 50 CasesThe American Journal of Surgical Pathology, 27
-
(2017)
DevCan: Probability of Developing or Dying of Cancer Software, version 6.7.5 [software program] -
F. Bray, A. Loos, S. Tognazzo, C. Vecchia (2005)
Ovarian cancer in Europe: Cross‐sectional trends in incidence and mortality in 28 countries, 1953–2000International Journal of Cancer, 113
-
Sun-Wei Guo, M. Zilberberg, L. Hummelshoj (2012)
Endometriosis and ovarian cancer.The Lancet. Oncology, 13 5
-
E. Nabel, Susan Shurin (2020)
National Cancer InstituteDefinitions
-
(2017)
SEER*Stat Database: Mortality‐All COD, Total US (1969‐2015)‐Linked To County Attributes‐Total US, 1969‐2015 Counties -
Kathleen Fairfield, K. Murray, J. Lachance, Heidi Wierman, C. Earle, E. Trimble, J. Warren (2014)
Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer.Gynecologic oncology, 134 3
-
A. Heravi‐Moussavi, M. Anglesio, S. Cheng, J. Senz, Winnie Yang, Leah Prentice, Anthony Fejes, C. Chow, A. Tone, S. Kalloger, N. Hamel, Andrew Roth, G. Ha, A. Wan, S. Maines-Bandiera, C. Salamanca, B. Pasini, B. Clarke, Anna Lee, Cheng-Han Lee, Chengquan Zhao, R. Young, Samuel Aparicio, P. Sorensen, M. Woo, Niki Boyd, Steven Jones, M. Hirst, M. Marra, B. Gilks, Sohrab Shah, W. Foulkes, G. Morin, D. Huntsman (2012)
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.The New England journal of medicine, 366 3
-
Clare Bankhead, C. Collins, H. Stokes-lampard, P. Rose, Sue Wilson, A. Clements, D. Mant, S. Kehoe, J. Austoker (2008)
Identifying symptoms of ovarian cancer: a qualitative and quantitative studyBjog, 115
-
M. Daly, R. Pilarski, Michael Berry, S. Buys, Meagan Farmer, S. Friedman, J. Garber, N. Kauff, S. Khan, C. Klein, W. Kohlmann, A. Kurian, J. Litton, L. Madlensky, S. Merajver, K. Offit, T. Pal, Gwen Reiser, K. Shannon, E. Swisher, S. Vinayak, Nicoleta Voian, J. Weitzel, M. Wick, G. Wiesner, M. Dwyer, S. Darlow (2017)
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Journal of the National Comprehensive Cancer Network : JNCCN, 15 1
-
(2017)
eds. Cancer in North America: 2010-2014 -
Zohreh Ketabi, Katarina Bartuma, I. Bernstein, S. Malander, H. Grönberg, E. Björck, S. Holck, M. Nilbert (2011)
Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.Gynecologic oncology, 121 3
-
(2017)
SEER*Stat software -
E. Bandera, V. Lee, L. Rodriguez-Rodriguez, C. Powell, L. Kushi (2016)
Racial/Ethnic Disparities in Ovarian Cancer Treatment and SurvivalClinical Cancer Research, 22
-
Sohrab Shah, M. Köbel, J. Senz, Ryan Morin, B. Clarke, Kimberly Wiegand, G. Leung, Abdalnasser Zayed, Erika Mehl, S. Kalloger, Mark Sun, Ryan Giuliany, E. Yorida, Steven Jones, R. Varhol, K. Swenerton, Dianne Miller, P. Clement, Colleen Crane, J. Madore, D. Provencher, P. Leung, A. deFazio, J. Khattra, G. Turashvili, Yongjun Zhao, Thomas Zeng, J. Glover, B. Vanderhyden, Chengquan Zhao, C. Parkinson, M. Jimenez-Linan, D. Bowtell, A. Mes-Masson, J. Brenton, Samuel Aparicio, Niki Boyd, M. Hirst, C. Gilks, M. Marra, D. Huntsman (2009)
Mutation of FOXL2 in granulosa-cell tumors of the ovary.The New England journal of medicine, 360 26
-
C. Pearce, C. Templeman, M. Rossing, Alice Lee, Aimee Near, P. Webb, C. Nagle, J. Doherty, K. Cushing-Haugen, K. Wicklund, J. Chang-Claude, R. Hein, G. Lurie, Lynne Wilkens, M. Carney, M. Goodman, K. Moysich, S. Kjaer, E. Høgdall, A. Jensen, E. Goode, B. Fridley, M. Larson, J. Schildkraut, Rachel Palmieri, D. Cramer, K. Terry, A. Vitonis, Linda Titus, A. Ziogas, W. Brewster, H. Anton-Culver, A. Gentry-Maharaj, S. Ramus, A. Anderson, D. Brueggmann, Peter Fasching, S. Gayther, David Huntsman, U. Menon, Roberta Ness, Malcolm Pike, H. Risch, Anna Wu, A. Berchuck (2012)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studiesThe Lancet. Oncology, 13
-
(2017)
Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome, 130
-
K. Alsop, S. Fereday, C. Meldrum, A. deFazio, C. Emmanuel, J. George, A. Dobrovic, M. Birrer, P. Webb, C. Stewart, M. Friedlander, S. Fox, D. Bowtell, G. Mitchell (2012)
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 21
-
Hannah Yang, W. Anderson, P. Rosenberg, B. Trabert, Gretchen Gierach, N. Wentzensen, K. Cronin, M. Sherman (2013)
Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 17
-
N. Wentzensen, E. Poole, B. Trabert, E. White, A. Arslan, Alpa Patel, V. Setiawan, K. Visvanathan, E. Weiderpass, H. Adami, H. Adami, A. Black, L. Bernstein, L. Brinton, J. Buring, L. Butler, S. Chamosa, T. Clendenen, L. Dossus, R. Fortner, S. Gapstur, M. Gaudet, I. Gram, P. Hartge, Judith Hoffman-Bolton, A. Idahl, Michael Jones, R. Kaaks, V. Kirsh, W. Koh, J. Lacey, I. Lee, E. Lundin, M. Merritt, N. Onland-Moret, U. Peters, J. Poynter, S. Rinaldi, K. Robien, T. Rohan, D. Sandler, C. Schairer, L. Schouten, Louise Sjöholm, S. Sieri, A. Swerdlow, A. Tjønneland, R. Travis, A. Trichopoulou, P. Brandt, L. Wilkens, A. Wolk, Hannah Yang, A. Zeleniuch‐Jacquotte, S. Tworoger (2016)
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 24
-
TM Friebel, SM Domchek, TR Rebbeck (2014)
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta‐analysis [serial online], 106
-
K. Schultz, Anne Harris, D. Schneider, R. Young, Jubilee Brown, D. Gershenson, L. Dehner, D. Hill, Y. Messinger, A. Frazier (2016)
Ovarian Sex Cord-Stromal Tumors.Journal of oncology practice, 12 10
-
E. Nieuwenhuysen, S. Lambrechts, D. Lambrechts, K. Leunen, F. Amant, I. Vergote (2013)
Genetic changes in nonepithelial ovarian cancerExpert Review of Anticancer Therapy, 13
-
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
-
M. Aranda, M. Mcgory, E. Sekeris, M. Maggard, C. Ko, D. Zingmond (2008)
Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer?Gynecologic oncology, 111 2
-
(2016)
Engineering, and Medicine. Ovarian Cancers: Evolving Paradigms in Research and Care -
B. Trabert, S. Coburn, A. Mariani, Hannah Yang, P. Rosenberg, Gretchen Gierach, N. Wentzensen, K. Cronin, M. Sherman (2018)
Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer RegistriesJNCI: Journal of the National Cancer Institute, 110
-
R. Bristow, Jenny Chang, A. Ziogas, L. Randall, H. Anton-Culver (2014)
High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.Gynecologic oncology, 132 2
-
R. Kurman, I. Shih (2016)
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.The American journal of pathology, 186 4
-
A. Wu, C. Pearce, C. Tseng, M. Pike (2015)
African Americans and Hispanics Remain at Lower Risk of Ovarian Cancer Than Non-Hispanic Whites after Considering Nongenetic Risk Factors and Oophorectomy RatesCancer Epidemiology, Biomarkers & Prevention, 24
-
C. Liao, S. Chow, Lee-may Chen, D. Kapp, A. Mann, J. Chan (2018)
Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.Gynecologic oncology, 149 2
-
SJ Ramus, H Song, E Dicks (2015)
Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer [serial online], 107
-
Ian Jacobs, U. Menon, Andy Ryan, A. Gentry-Maharaj, M. Burnell, Jatinderpal Kalsi, N. Amso, S. Apostolidou, E. Benjamin, Derek Cruickshank, Danielle Crump, S. Davies, A. Dawnay, Stephen Dobbs, Gwendolen Fletcher, Jeremy Ford, Keith Godfrey, Richard Gunu, M. Habib, Rachel Hallett, J. Herod, H. Jenkins, C. Karpinskyj, Simon Leeson, S. Lewis, William Liston, Alberto Lopes, T. Mould, John Murdoch, David Oram, D. Rabideau, K. Reynolds, Ian Scott, M. Seif, Aarti Sharma, Naveena Singh, Julie Taylor, Fiona Warburton, Martin Widschwendter, K. Williamson, R. Woolas, Lesley Fallowfield, Alistair McGuire, S. Campbell, Mahesh Parmar, S. Skates (2016)
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialLancet (London, England), 387
-
(2016)
SEER Program Coding and Staging Manual 2016. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2016 -
E. Calle, S. Gapstur, Alpa Patel, L. Maso, R. Talamini, A. Chetrit, G. Hirsh-Yechezkel, F. Lubin, S. Sadetzki, E. Banks, V. Beral, D. Bull, K. Callaghan, B. Crossley, K. Gaitskell, A. Goodill, J. Green, C. Hermon, T. Key, K. Moser, G. Reeves, F. Sitas, R. Collins, R. Doll, R. Peto, C. González, N. Lee, P. Marchbanks, H. Ory, H. Peterson, P. Wingo, N. Martin, T. Pardthaisong, S. Silpisornkosol, C. Theetranont, B. Boosiri, S. Chutivongse, P. Jimakorn, P. Virutamasen, C. Wongsrichanalai, A. Tjønneland, L. Titus-Ernstoff, T. Byers, T. Rohan, B. Mosgaard, M. Vessey, D. Yeates, J. Freudenheim, J. Chang-Claude, R. Kaaks, K. Anderson, A. Folsom, K. Robien, J. Hampton, P. Newcomb, M. Rossing, D. Thomas, N. Weiss, E. Riboli, F. Clavel-Chapelon, D. Cramer, S. Hankinson, S. Tworoger, S. Franceschi, C. Vecchia, E. Negri, H. Adami, C. Magnusson, T. Riman, E. Weiderpass, A. Wolk, L. Schouten, P. Brandt, N. Chantarakul, S. Koetsawang, D. Rachawat, D. Palli, A. Black, L. Brinton, D. Freedman, P. Hartge, A. Hsing, Jr Lacey, R. Hoover, C. Schairer, M. Urban, S. Graff-Iversen, R. Selmer, C. Bain, A. Green, D. Purdie, V. Siskind, P. Webb, K. Moysich, S. McCann, P. Hannaford, C. Kay, C. Binns, Andy Lee, M. Zhang, R. Ness, P. Nasca, P. Coogan, J. Palmer, L. Rosenberg, J. Kelsey, R. Paffenbarger, A. Whittemore, K. Katsouyanni, A. Trichopoulou, D. Trichopoulos, A. Tzonou, A. Dabancens, L. Martínez, R. Molina, O. Salas, M. Goodman, G. Lurie, M. Carney, L. Wilkens, L. Hartman, J. Manjer, H. Olsson, J. Grisso, M. Morgan, J. Wheeler, C. Bunker, R. Edwards, F. Modugno, P. Peeters, J. Casagrande, M. Pike, R. Ross, A. Wu, A. Miller, M. Kumle, I. Gram, E. Lund, L. Mcgowan, X. Shu, W. Zheng, T. Farley, S. Holck, O. Meirik, H. Risch (2012)
Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studiesThe Lancet. Oncology, 13
-
(2013)
International Classification of Diseases, 10th revision -
V. Sopik, J. Iqbal, B. Rosen, S. Narod (2015)
Why have ovarian cancer mortality rates declined? Part I. Incidence.Gynecologic oncology, 138 3
-
P. Moorman, L. Havrilesky, J. Gierisch, R. Coeytaux, W. Lowery, Rachel Urrutia, M. Dinan, Amanda McBroom, V. Hasselblad, G. Sanders, E. Myers (2013)
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 33
-
R. Matsuno, M. Sherman, K. Visvanathan, M. Goodman, B. Hernandez, C. Lynch, O. Ioffe, D. Horio, C. Platz, S. Altekruse, R. Pfeiffer, W. Anderson (2013)
Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repositoryCancer Causes & Control, 24
-
L. Peres, K. Cushing-Haugen, M. Köbel, H. Harris, A. Berchuck, M. Rossing, J. Schildkraut, J. Doherty (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease StageJNCI: Journal of the National Cancer Institute, 111
-
T. Friebel, S. Domchek, T. Rebbeck (2014)
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.Journal of the National Cancer Institute, 106 6
-
R. Siegel, K. Miller, A. Jemal (2018)
Cancer statistics, 2018CA: A Cancer Journal for Clinicians, 68
-
J. Prat (2012)
New insights into ovarian cancer pathology.Annals of oncology : official journal of the European Society for Medical Oncology, 23 Suppl 10
-
/Page/ Document/RecommendationStatementFinal/ brca-related-cancer-risk-assessment-geneticcounseling-and-genetic-testing -
R. Bristow, M. Powell, N. Al-Hammadi, Ling Chen, J. Miller, P. Roland, D. Mutch, W. Cliby (2013)
Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.Journal of the National Cancer Institute, 105 11
-
(2000)
International Classification of Diseases for Oncology -
M. Matz, M. Coleman, M. Sant, M. Chirlaque, O. Visser, M. Gore, C. Allemani (2017)
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).Gynecologic oncology, 144 2
-
S. Coburn, F. Bray, Mark Sherman, B. Trabert (2017)
International patterns and trends in ovarian cancer incidence, overall and by histologic subtypeInternational Journal of Cancer, 140
-
(2004)
Frequency of symptoms of ovarian cancer in women presenting to primary care clinics -
R. Kurman (2013)
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.Annals of oncology : official journal of the European Society for Medical Oncology, 24 Suppl 10
-
A. Rosenthal, L. Fraser, S. Philpott, R. Manchanda, M. Burnell, Philip Badman, R. Hadwin, I. Rizzuto, E. Benjamin, N. Singh, D. Evans, D. Eccles, A. Ryan, R. Liston, A. Dawnay, Jeremy Ford, Richard Gunu, J. Mackay, S. Skates, U. Menon, I. Jacobs (2017)
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyJournal of Clinical Oncology, 35
-
M. Daly, R. Pilarski, J. Axilbund, Michael Berry, S. Buys, B. Crawford, Meagan Farmer, S. Friedman, J. Garber, S. Khan, C. Klein, W. Kohlmann, A. Kurian, J. Litton, L. Madlensky, P. Marcom, S. Merajver, K. Offit, T. Pal, H. Rana, Gwen Reiser, Mark Robson, K. Shannon, E. Swisher, Nicoleta Voian, J. Weitzel, A. Whelan, M. Wick, G. Wiesner, M. Dwyer, Rashmi Kumar, S. Darlow (2016)
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Journal of the National Comprehensive Cancer Network : JNCCN, 14 2
-
S. Modesitt (2011)
Hereditary breast and ovarian cancer syndromeDefinitions
-
B. Norquist, M. Harrell, M. Brady, T. Walsh, Ming Lee, S. Gulsuner, S. Bernards, S. Casadei, Qian Yi, R. Burger, J. Chan, S. Davidson, R. Mannel, P. DiSilvestro, H. Lankes, N. Ramirez, M. King, E. Swisher, M. Birrer (2016)
Inherited Mutations in Women With Ovarian Carcinoma.JAMA oncology, 2 4
-
W Hamilton, TJ Peters, C Bankhead, D Sharp (2009)
Risk of ovarian cancer in women with symptoms in primary care: population based case‐control study [serial online], 339
-
D. Cibula, M. Widschwendter, O. Májek, L. Dušek (2011)
Tubal ligation and the risk of ovarian cancer: review and meta-analysis.Human reproduction update, 17 1
-
K. Kuchenbaecker, J. Hopper, D. Barnes, K. Phillips, T. Mooij, M. Roos-Blom, Sarah Jervis, F. Leeuwen, R. Milne, N. Andrieu, D. Goldgar, M. Terry, M. Rookus, D. Easton, A. Antoniou, L. McGuffog, D. Evans, D. Barrowdale, D. Frost, J. Adlard, K. Ong, L. Izatt, M. Tischkowitz, R. Eeles, R. Davidson, S. Hodgson, Steve Ellis, C. Noguès, C. Lasset, D. Stoppa-Lyonnet, J. Fricker, L. Faivre, P. Berthet, M. Hooning, L. Kolk, C. Kets, M. Adank, E. John, Wendy Chung, I. Andrulis, M. Southey, M. Daly, S. Buys, A. Osorio, C. Engel, K. Kast, R. Schmutzler, T. Caldés, A. Jakubowska, J. Simard, M. Friedlander, S. McLachlan, E. Macháčková, L. Foretova, Y. Tan, C. Singer, E. Oláh, A. Gerdes, B. Arver, H. Olsson (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersJAMA, 317
-
B. Long, Jenny Chang, A. Ziogas, K. Tewari, H. Anton-Culver, R. Bristow (2014)
Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.American journal of obstetrics and gynecology, 212 4
-
S. Narod, V. Sopik, V. Giannakeas (2016)
Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial.Gynecologic oncology, 141 2
-
(2016)
Ovarian Cancers: Evolving Paradigms in Research and Care -
V. Bonadona, B. Bonaïti, S. Olschwang, S. Grandjouan, L. Huiart, M. Longy, R. Guimbaud, B. Buecher, Y. Bignon, O. Caron, C. Colas, C. Noguès, S. Lejeune-Dumoulin, L. Olivier-Faivre, Florence Polycarpe-Osaer, T. Nguyen, F. Desseigne, J. Saurin, P. Berthet, D. Leroux, J. Duffour, S. Manouvrier, T. Frebourg, H. Sobol, C. Lasset, C. Bonaïti‐pellié (2011)
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.JAMA, 305 22
-
Honglin Song, E. Dicks, S. Ramus, J. Tyrer, M. Intermaggio, J. Hayward, C. Edlund, David Conti, P. Harrington, Lindsay Fraser, S. Philpott, C. Anderson, Adam Rosenthal, A. Gentry-Maharaj, D. Bowtell, K. Alsop, M. Cicek, J. Cunningham, B. Fridley, J. Alsop, M. Jimenez-Linan, E. Høgdall, Claus Høgdall, Allan Jensen, Susanne Kjaer, J. Lubiński, T. Huzarski, A. Jakubowska, J. Gronwald, S. Poblete, Shashi Lele, Lara Sucheston-Campbell, K. Moysich, K. Odunsi, E. Goode, Usha Menon, Ian Jacobs, S. Gayther, Paul Pharoah (2015)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 26
-
(2017)
DevCan: Probability of Developing or Dying of Cancer Software -
(2017)
Joinpoint Regression Program, version 4.5.0.1 [software program] -
R. Ness (2003)
Endometriosis and ovarian cancer: thoughts on shared pathophysiology.American journal of obstetrics and gynecology, 189 1
-
A. Berchuck, L. Havrilesky, N. Kauff (2017)
Is There a Role for Ovarian Cancer Screening in High-Risk Women?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 13
-
S. Ramus, Honglin Song, E. Dicks, J. Tyrer, A. Rosenthal, M. Intermaggio, L. Fraser, A. Gentry-Maharaj, J. Hayward, S. Philpott, C. Anderson, C. Edlund, D. Conti, P. Harrington, D. Barrowdale, D. Bowtell, K. Alsop, G. Mitchell, M. Cicek, J. Cunningham, B. Fridley, J. Alsop, M. Jimenez-Linan, S. Poblete, S. Lele, Lara Sucheston-Campbell, K. Moysich, W. Sieh, V. McGuire, J. Lester, N. Bogdanova, M. Dürst, P. Hillemanns, K. Odunsi, A. Whittemore, B. Karlan, T. Dörk, E. Goode, U. Menon, I. Jacobs, A. Antoniou, P. Pharoah, S. Gayther (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.Journal of the National Cancer Institute, 107 11
-
D. Grossman, S. Curry, D. Owens, M. Barry, K. Davidson, Chyke Doubeni, J. Epling, A. Kemper, A. Krist, A. Kurth, C. Landefeld, C. Mangione, M. Phipps, Michael Silverstein, M. Simon, Chien-Wen Tseng (2018)
Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation StatementJAMA, 319
-
(2016)
SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data‐Cancer in North America (CiNA) Analytic File, 1995‐2014, for Expanded Races, Custom File With County, American Cancer Society Facts and Figures Projection Project (which includes data from the Centers for Disease Control and Prevention's National Program of Cancer Registries [NPCR], the Canadian Counsel of Cancer Registry's Provincial and Territorial Registries, and the National Cancer Institute's SEER Registries), certified by the NAACCR as meeting high‐quality incidence data standards for the specified time periods -
G Copeland, A Lake, R Firth (2017)
Cancer in North America: 2010‐2014. Volume Two: Registry‐specific Cancer Incidence in the United States and Canada -
H. Park, J. Ruterbusch, M. Cote (2017)
Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic SubtypesCancer Epidemiology, Biomarkers & Prevention, 26
-
(2017)
Cancer in North America: 2010‐2014. Volume One: Combined Cancer Incidence for the United States, Canada and North America -
P. Pinsky, Kelly Yu, B. Kramer, A. Black, S. Buys, E. Partridge, J. Gohagan, C. Berg, P. Prorok (2016)
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.Gynecologic oncology, 143 2
-
V. Beral, K. Gaitskell, C. Hermon, K. Moser, G. Reeves, R. Peto (2015)
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studiesLancet (London, England), 385
-
U. Force (2015)
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement.American family physician, 91 2
-
A. Finch, J. Lubiński, P. Møller, C. Singer, B. Karlan, L. Senter, B. Rosen, L. Maehle, P. Ghadirian, C. Cybulski, T. Huzarski, A. Eisen, W. Foulkes, C. Kim-sing, P. Ainsworth, N. Tung, H. Lynch, S. Neuhausen, K. Metcalfe, I. Thompson, Joan Murphy, P. Sun, S. Narod (2014)
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 15
-
N Howlader, AM Noone, M Krapcho (2017)
SEER Cancer Statistics Review, 1975‐2014 -
Michelle Jones, D. Kamara, B. Karlan, P. Pharoah, S. Gayther (2017)
Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.Gynecologic oncology, 147 3
-
Vanessa Jacoby, Victor Fujimoto, Linda Giudice, M. Kuppermann, A. Washington (2010)
Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.American journal of obstetrics and gynecology, 202 6
-
S. Boussios, G. Zarkavelis, E. Seraj, I. Zerdes, Konstantina Tatsi, G. Pentheroudakis (2016)
Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies.Anticancer research, 36 10
-
Collaborative Cancer (2008)
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controlsThe Lancet, 371
-
C. Pearce, M. Rossing, Alice Lee, R. Ness, P. Webb, G. Chenevix-Trench, S. Jordan, D. Stram, J. Chang-Claude, R. Hein, S. Nickels, G. Lurie, P. Thompson, M. Carney, M. Goodman, K. Moysich, E. Høgdall, A. Jensen, E. Goode, B. Fridley, J. Cunningham, R. Vierkant, R. Weber, A. Ziogas, H. Anton-Culver, S. Gayther, A. Gentry-Maharaj, U. Menon, S. Ramus, L. Brinton, N. Wentzensen, J. Lissowska, M. García-Closas, L. Massuger, L. Kiemeney, A. Altena, K. Aben, A. Berchuck, J. Doherty, E. Iversen, V. McGuire, P. Moorman, P. Pharoah, M. Pike, H. Risch, W. Sieh, D. Stram, K. Terry, A. Whittemore, A. Wu, J. Schildkraut, S. Kjaer (2013)
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 22 5
-
W. Hamilton, T. Peters, C. Bankhead, D. Sharp (2009)
Risk of ovarian cancer in women with symptoms in primary care: population based case-control studyThe BMJ, 339
-
R. Bristow, Jenny Chang, A. Ziogas, Belinda Campos, L. Chávez, H. Anton-Culver (2015)
Sociodemographic Disparities in Advanced Ovarian Cancer Survival and Adherence to Treatment GuidelinesObstetrics & Gynecology, 125
-
A. Meyn, Boon Lim (2017)
A paradigm shift in the origin of ovarian cancer: the ovary is no longer to blameBJOG: An International Journal of Obstetrics & Gynaecology, 124
-
Joan Walker, C. Powell, Lee-may Chen, J. Carter, Victoria Jump, L. Parker, M. Borowsky, R. Gibb (2015)
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerCancer, 121
-
L. Peres, H. Risch, K. Terry, Penelope Webb, M. Goodman, A. Wu, A. Alberg, E. Bandera, J. Barnholtz-Sloan, M. Bondy, M. Cote, E. Funkhouser, P. Moorman, E. Peters, A. Schwartz, P. Terry, A. Manichaikul, Sarah Abbott, F. Camacho, S. Jordan, C. Nagle, Mary Rossing, J. Doherty, F. Modugno, K. Moysich, R. Ness, A. Berchuck, L. Cook, N. Le, A. Brooks-Wilson, W. Sieh, A. Whittemore, V. McGuire, J. Rothstein, H. Anton-Culver, A. Ziogas, C. Pearce, C. Tseng, M. Pike, J. Schildkraut (2018)
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.International journal of epidemiology
-
J. Barnholtz-Sloan, A. Schwartz, F. Qureshi, S. Jacques, J. Malone, A. Munkarah (2003)
Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.American journal of obstetrics and gynecology, 189 4
-
M Adamo, L Dickie, J Ruhl (2016)
SEER Program Coding and Staging Manual 2016 -
(2009)
Draft Report from the ICD-2 Research Program Task Force -
E. Gabai-Kapara, A. Lahad, B. Kaufman, E. Friedman, S. Segev, P. Renbaum, R. Beeri, M. Gal, J. Grinshpun‐Cohen, Karen Djemal, Jessica Mandell, Ming Lee, U. Beller, R. Catane, M. King, E. Levy-Lahad (2014)
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2Proceedings of the National Academy of Sciences, 111
- Publisher
- Wiley
- Copyright
- © 2018 American Cancer Society
- ISSN
- 0007-9235
- eISSN
- 1542-4863
- DOI
- 10.3322/caac.21456
- Publisher site
- See Article on Publisher Site
Abstract
Journal
CA A Cancer Journal for Clinicians – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;